Albert David Limited
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Market Cap & Net Worth: Albert David Limited (ALBERTDAVD)
Albert David Limited (NSE:ALBERTDAVD) has a market capitalization of $44.15 Million (₹3.82 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #26536 globally and #1413 in its home market, demonstrating a -1.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Albert David Limited's stock price ₹669.90 by its total outstanding shares 5707162 (5.71 Million).
Albert David Limited Market Cap History: 2016 to 2026
Albert David Limited's market capitalization history from 2016 to 2026. Data shows growth from $20.15 Million to $44.15 Million (9.36% CAGR).
Albert David Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Albert David Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Albert David Limited's market cap is 0.01 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.28x
Albert David Limited's market cap is 0.28 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $20.15 Million | $3.21 Billion | $479.96 Million | 0.01x | 0.04x |
| 2017 | $21.04 Million | $3.03 Billion | $120.35 Million | 0.01x | 0.17x |
| 2018 | $24.81 Million | $2.88 Billion | $98.41 Million | 0.01x | 0.25x |
| 2019 | $25.18 Million | $3.13 Billion | $266.40 Million | 0.01x | 0.09x |
| 2020 | $27.85 Million | $3.18 Billion | $191.69 Million | 0.01x | 0.15x |
| 2021 | $38.42 Million | $2.46 Billion | $221.43 Million | 0.02x | 0.17x |
| 2022 | $36.59 Million | $3.12 Billion | $352.58 Million | 0.01x | 0.10x |
| 2023 | $63.70 Million | $3.42 Billion | $361.75 Million | 0.02x | 0.18x |
| 2024 | $87.46 Million | $3.60 Billion | $754.20 Million | 0.02x | 0.12x |
| 2025 | $48.54 Million | $3.46 Billion | $172.01 Million | 0.01x | 0.28x |
Competitor Companies of ALBERTDAVD by Market Capitalization
Companies near Albert David Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Albert David Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Albert David Limited Historical Marketcap From 2016 to 2026
Between 2016 and today, Albert David Limited's market cap moved from $20.15 Million to $ 44.15 Million, with a yearly change of 9.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹44.15 Million | -9.06% |
| 2025 | ₹48.54 Million | -44.50% |
| 2024 | ₹87.46 Million | +37.29% |
| 2023 | ₹63.70 Million | +74.11% |
| 2022 | ₹36.59 Million | -4.76% |
| 2021 | ₹38.42 Million | +37.96% |
| 2020 | ₹27.85 Million | +10.59% |
| 2019 | ₹25.18 Million | +1.48% |
| 2018 | ₹24.81 Million | +17.93% |
| 2017 | ₹21.04 Million | +4.40% |
| 2016 | ₹20.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Albert David Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $44.15 Million USD |
| MoneyControl | $44.15 Million USD |
| MarketWatch | $44.15 Million USD |
| marketcap.company | $44.15 Million USD |
| Reuters | $44.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.